HC Wainwright reiterates Buy on LifeMD, sets $9 target
HC Wainwright & Co. reiterated a Buy rating on LifeMD and set a $9.00 price target.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.